Entyvio® (vedolizumab) UK Website
Entyvio is a treatment for adults with moderately to severely active ulcerative colitis and moderately to severely active Crohn’s disease, two types of inflammatory bowel disease (IBD).
This website contains useful information about Entyvio for different audiences: there is a section with product and prescribing information for healthcare professionals, a section for patients who have been prescribed Entyvio, a further section with IBD information for the general public and a section containing resources for journalists and the media.
Reporting of Side Effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed on this website or in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more information on the safety of this medicine.